Amount of private investments in Skolkovo can reach 367B RUB
06 August 2013
According to the Chief of the Fund Skolkovo Viktor Vekselberg, till the year 2020 the amount of private investments in the project of innovation center can reach 367B RUB, and after the year 2025 the budget funds for the project will not be required.
Russian government to regulate prices for essential drugs
02 August 2013
The Russian government is considering tightening its pricing policy in the domestic market for essential drugs, with the aim of preventing unreasonable price rises for them in the future. According to the Russian Ministry of Health, it is planned that ceiling prices for foreign essential drugs sold in Russia will not exceed the average European prices for the same types of drugs.
J&J buys into ReVision Optics' $55M financing round
30 July 2013
ReVision Optics attracted an impressive $55 million in new equity financing from the likes of Johnson & Johnson ($JNJ) and a Russian investor group--a massive cash infusion that will advance its hydrogel eye implant designed to help reduce the need for reading glasses.
New Russian company to build $85M plant
30 July 2013
NovaMedica was formed out of Domain Associates' partnership with RUSNANO.
$85m Plant Demonstrates Russia's Commitment to Pharma 2020, says NovaMedica
29 July 2013
NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.
NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created
26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
BioPharmCluster “Nothern” and Technopolis Moscow have executed a cooperation
24 July 2013
BioPharmCluster “Nothern”, created on the basis of Moscow Institute of Physics and Technology, and Technopolis Moscow executed a memorandum on cooperation in the sphere of innovation technologies development in hi-tech economy branches.
Pharma industry on cusp of golden era, PwC says
23 July 2013
Russia’s pharma-industry is on the cusp of a golden era, states a recent report from PwC on the sector called “Pharma 2020: From Vision to Decision”. Major scientific and technological advances, alongside socio-demographic changes and increasing demand for medicines, will revive pharma’s fortunes post 2020, PwC’s experts claim.
Skolkovo and South California University agreed on cooperation
19 July 2013
Technopark Skolkovo visited deputy Dean of natural sciences Faculty of the South California University, professor of chemistry Charles McCann.
Indian drug makers fit into Russia’s pharma strategy
19 July 2013
With Russia reshaping its pharmaceutical sector as part of the Pharma2020 concept, Indian drug manufacturers and exporters are searching for new ways to expand their business.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024